← Back to Search

Gastric Sleeve

Bariatric Surgery for Obesity

N/A
Recruiting
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will study the effects of bariatric surgery on dyspnea and quality of life in people with obesity. Improved understanding of this relationship can lead to better treatments.

Who is the study for?
This trial is for English/Spanish-speaking adults over 18 with obesity, experiencing shortness of breath and seeking gastric sleeve surgery at the Ronald Reagan medical center. They must understand questionnaires and give informed consent. Excluded are those with mental disorders, serious heart or lung diseases, past gastrointestinal surgeries, recent hospitalization, renal failure or cancer history.Check my eligibility
What is being tested?
The study examines how weight loss from bariatric surgery (gastric sleeve) affects shortness of breath in obese individuals. It aims to see if this surgical method can improve patients' quality of life by reducing dyspnea using a validated health questionnaire (PROMIS+HF 27).See study design
What are the potential side effects?
While not specified here, typical side effects from bariatric surgery may include nausea, vomiting, digestive issues like acid reflux or constipation, nutritional deficiencies due to reduced food intake and absorption changes post-surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dyspnea
Secondary outcome measures
Health related quality of life

Trial Design

2Treatment groups
Experimental Treatment
Group I: Medical weight lossExperimental Treatment1 Intervention
The medical weight loss intervention will follow the University of California at Los Angeles's (UCLA) Research For Obesity (RFO) standard protocol. Over a period of 12 months, patients in the medical weight loss group will follow a very loc caloric diet (VLCD) at the UCLA RFO program. All study patients will be prescribed a VLCD, an exercise regimen and will participate in group classes on behavioral modification. The caloric intake consists of a commercially prepared meal replacement powder supplying 700-800 cal/day. Each formula packet provides 100kcal and 15g of high biological value protein, and the daily allowance of required minerals and vitamins.
Group II: Bariatric surgeryExperimental Treatment1 Intervention
Gastric sleeve resection will be performed by experienced surgeons. Postoperative care will follow UCLA's postoperative care pathways for gastric sleeve resection.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bariatric surgery
2013
Completed Phase 4
~15460

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterOTHER
1,048 Previous Clinical Trials
1,053,695 Total Patients Enrolled
Northwestern UniversityOTHER
1,589 Previous Clinical Trials
917,047 Total Patients Enrolled
University of California, Los AngelesLead Sponsor
1,532 Previous Clinical Trials
10,265,228 Total Patients Enrolled

Media Library

Bariatric surgery (Gastric Sleeve) Clinical Trial Eligibility Overview. Trial Name: NCT05812183 — N/A
Shortness of Breath Research Study Groups: Bariatric surgery, Medical weight loss
Shortness of Breath Clinical Trial 2023: Bariatric surgery Highlights & Side Effects. Trial Name: NCT05812183 — N/A
Bariatric surgery (Gastric Sleeve) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05812183 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings available for those wishing to participate in this clinical trial?

"According to clinicaltrials.gov, this medical trial is presently enrolling candidates. It was initially advertised on July 9th 2023 and has had its details updated as recently as the 12th of July in the same year."

Answered by AI

What is the total enrollment count of this clinical trial?

"Indeed, the information available on clinicaltrials.gov confirms that this study is actively recruiting patients. It was initially posted on July 9th 2023 and revised most recently on July 12th 2023. The medical trial aims to enrol 40 individuals from one single centre."

Answered by AI

Who else is applying?

What site did they apply to?
Surgery Departement, UCLA
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
2

Why did patients apply to this trial?

I,D LIKE TO TRY.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity
Edward Harry Livingston 2023. "Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05812183.
All > Weight Loss Anaheim
~22 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top